HomeCompareNEAPF vs MRK

NEAPF vs MRK: Dividend Comparison 2026

NEAPF yields 147.06% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEAPF wins by $22.54M in total portfolio value
10 years
NEAPF
NEAPF
● Live price
147.06%
Share price
$1.36
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.60M
Annual income
$9,667,205.19
Full NEAPF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NEAPF vs MRK

📍 NEAPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEAPFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEAPF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NEAPF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEAPF
Annual income on $10K today (after 15% tax)
$12,500.00/yr
After 10yr DRIP, annual income (after tax)
$8,217,124.41/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, NEAPF beats the other by $8,208,796.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEAPF + MRK for your $10,000?

NEAPF: 50%MRK: 50%
100% MRK50/50100% NEAPF
Portfolio after 10yr
$11.33M
Annual income
$4,838,501.66/yr
Blended yield
42.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NEAPF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEAPF buys
0
MRK buys
0
No recent congressional trades found for NEAPF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEAPFMRK
Forward yield147.06%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$22.60M$56.8K
Annual income after 10y$9,667,205.19$9,798.13
Total dividends collected$20.88M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NEAPF vs MRK ($10,000, DRIP)

YearNEAPF PortfolioNEAPF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$25,406$14,705.88$11,206$366.19+$14.2KNEAPF
2$62,102$34,917.38$12,650$502.35+$49.5KNEAPF
3$146,216$79,767.65$14,407$694.19+$131.8KNEAPF
4$331,975$175,523.78$16,585$967.82+$315.4KNEAPF
5$727,658$372,444.73$19,342$1,363.89+$708.3KNEAPF
6$1,541,551$762,956.42$22,913$1,947.19+$1.52MNEAPF
7$3,160,048$1,510,588.88$27,662$2,823.89+$3.13MNEAPF
8$6,275,251$2,893,998.93$34,159$4,173.35+$6.24MNEAPF
9$12,085,478$5,370,960.29$43,337$6,308.80+$12.04MNEAPF
10$22,598,667$9,667,205.19$56,776$9,798.13+$22.54MNEAPF

NEAPF vs MRK: Complete Analysis 2026

NEAPFStock

Nearmap Ltd provides cloud-based geospatial information services in Australia, New Zealand, Canada, and North America. The company offers aerial imagery maps, such as vertical and oblique imagery, Nearmap 3D, Nearmap AI, and Nearmap on OpenSolar. Its solutions are used in architecture and engineering, construction, insurance and financial services, property and real estate, roofing, solar, telecommunication, transportation and logistics, and utilities, as well as government sector. The company was formerly known as ipernica ltd and changed its name to Nearmap Ltd in November 2012. Nearmap Ltd was incorporated in 1998 and is based in Sydney, Australia. As of December 6, 2022, Nearmap Ltd was taken private.

Full NEAPF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NEAPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEAPF vs SCHDNEAPF vs JEPINEAPF vs ONEAPF vs KONEAPF vs MAINNEAPF vs JNJNEAPF vs ABBVNEAPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.